Open-Label, randomized, partially balanced, incomplete block design study to evaluate the hormone exposure from commercial ORTHO EVRA [ethinylestradiol/norelgestromin]

Trial Profile

Open-Label, randomized, partially balanced, incomplete block design study to evaluate the hormone exposure from commercial ORTHO EVRA [ethinylestradiol/norelgestromin]

Completed
Phase of Trial: Phase I

Latest Information Update: 18 May 2007

At a glance

  • Drugs Ethinylestradiol/norelgestromin (Primary)
  • Indications Pregnancy
  • Focus Pharmacokinetics
  • Sponsors Janssen Research & Development
  • Most Recent Events

    • 24 Aug 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top